Abbott Laboratories

Abbott Laboratories
Company type	Public
Traded as	NYSE: ABT; S&P 100 component; S&P 500 component;
Industry	Health care; Medical devices; Pharmaceutical;
Founded	1888 (as Abbott Alkaloidal Company) in Ravenswood, Chicago
Founder	Wallace Calvin Abbott
Successor	AbbVie
Headquarters	Green Oaks, Illinois, U.S.
Area served	Worldwide
Key people	Robert B. Ford; (chairman & CEO); Robert Funck; (EVP & CFO);
Products	Pharmaceutical drugs; Generic drugs; Medical devices; Diagnostic assays; Dietary supplements; Nutritionals;
Revenue	US$40.1 billion (2023)
Operating income	US$6.48 billion (2023)
Net income	US$5.72 billion (2023)
Total assets	US$73.2 billion (2023)
Total equity	US$38.8 billion (2023)
Number of employees	c. 114,000 (2023)
Website	abbott.com
	Footnotes / references;

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.^[3]^[4]

Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.

^ Japsen, Bruce. "After 20 Years, Abbott Labs CEO Miles White Has Successor in Mind". Forbes. Archived from the original on 2 February 2023. Retrieved 10 September 2019.
^ "US SEC: Form 10-K Abbott Laboratories". U.S. Securities and Exchange Commission. 16 February 2024.
^ "Abbott Completes Separation of Research-Based Pharmaceuticals Business" (Press release). PR Newswire. 2 January 2013. Archived from the original on 14 January 2013.
^ "More than splitting pills: Health care giant Abbott Laboratories ready to spin off AbbVie". Chicago Tribune. 30 December 2012. Archived from the original on 3 July 2021. Retrieved 14 April 2023.

[1] Japsen, Bruce. "After 20 Years, Abbott Labs CEO Miles White Has Successor in Mind". Forbes. Archived from the original on 2 February 2023. Retrieved 10 September 2019.

[10-K_2023-2] "US SEC: Form 10-K Abbott Laboratories". U.S. Securities and Exchange Commission. 16 February 2024.

[3] "Abbott Completes Separation of Research-Based Pharmaceuticals Business" (Press release). PR Newswire. 2 January 2013. Archived from the original on 14 January 2013.

[4] "More than splitting pills: Health care giant Abbott Laboratories ready to spin off AbbVie". Chicago Tribune. 30 December 2012. Archived from the original on 3 July 2021. Retrieved 14 April 2023.

[1]

[2]

[3]

[4]